Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Saliba

Showing results (31-40 of 67) with videos related to

Pageof 7
Sort By:
Transplantation Proceedings|February 1, 1989
CMV hyperimmune globulin prophylaxis after liver transplantation: a prospective randomized controlled studyF Saliba, J L Arulnaden, J Gugenheim, et al.
Lancet (London, England)|December 31, 1997
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]E Gane, F Saliba, G J Valdecasas, et al.
Lancet (London, England)|May 28, 1988
Fatal acute HIV infection with aplastic anaemia, transmitted by liver graftD Samuel, D Castaing, R Adam, et al.
Transplantation Proceedings|February 1, 1993
Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipientsF Saliba, D Eyraud, D Samuel, et al.
Journal of Hepatology|May 1, 1992
Fipexide-induced fulminant hepatitis. Report of three cases with emergency liver transplantationF Durand, D Samuel, J Bernuau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 18, 2015
Ad Integrum Functional and Volumetric Recovery in Right Lobe Living Donors: Is It Really Complete 1 Year After Donor Hepatectomy?J Duclos, P Bhangui, C Salloum, et al.
Annals of Surgery|August 1, 1995
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experienceH Bismuth, D Samuel, D Castaing, et al.
Investigational New Drugs|September 22, 2012
Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunctionJ P Delord, A Ravaud, J Bennouna, et al.
Clinical Pharmacology and Therapeutics|May 7, 2010
CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than AspirinN Carbonell, C Verstuyft, J Massard, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 10, 2014
Invasive fungal infections in solid organ transplant recipientsJ Gavaldà, Y Meije, J Fortún, et al.
Pageof 7

Showing results (31-40 of 67) with videos related to

Sort By:
Pageof 7
Transplantation Proceedings|February 1, 1989
CMV hyperimmune globulin prophylaxis after liver transplantation: a prospective randomized controlled studyF Saliba, J L Arulnaden, J Gugenheim, et al.
Lancet (London, England)|December 31, 1997
Randomised trial of efficacy and safety of oral ganciclovir in the prevention of cytomegalovirus disease in liver-transplant recipients. The Oral Ganciclovir International Transplantation Study Group [corrected]E Gane, F Saliba, G J Valdecasas, et al.
Lancet (London, England)|May 28, 1988
Fatal acute HIV infection with aplastic anaemia, transmitted by liver graftD Samuel, D Castaing, R Adam, et al.
Transplantation Proceedings|February 1, 1993
Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipientsF Saliba, D Eyraud, D Samuel, et al.
Journal of Hepatology|May 1, 1992
Fipexide-induced fulminant hepatitis. Report of three cases with emergency liver transplantationF Durand, D Samuel, J Bernuau, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|August 18, 2015
Ad Integrum Functional and Volumetric Recovery in Right Lobe Living Donors: Is It Really Complete 1 Year After Donor Hepatectomy?J Duclos, P Bhangui, C Salloum, et al.
Annals of Surgery|August 1, 1995
Orthotopic liver transplantation in fulminant and subfulminant hepatitis. The Paul Brousse experienceH Bismuth, D Samuel, D Castaing, et al.
Investigational New Drugs|September 22, 2012
Phase I and pharmacokinetic study of IV vinflunine in cancer patients with liver dysfunctionJ P Delord, A Ravaud, J Bennouna, et al.
Clinical Pharmacology and Therapeutics|May 7, 2010
CYP2C9*3 Loss-of-Function Allele Is Associated With Acute Upper Gastrointestinal Bleeding Related to the Use of NSAIDs Other Than AspirinN Carbonell, C Verstuyft, J Massard, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|May 10, 2014
Invasive fungal infections in solid organ transplant recipientsJ Gavaldà, Y Meije, J Fortún, et al.
Pageof 7